Gujarat Terce Laboratories share news, announcements and annual reports
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Gujarat Terce Laboratories Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1993
Last close ₹41.12down ₹1.83 (4.26%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹42.95.
30 Oct: open ₹44.00, high ₹44.00, low ₹40.50
52-week range of traded prices to 30 Oct 2026
₹29.00Low, 30 Mar 2026₹50.00High, 13 Jan 2026
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹32 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.35
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 12.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.29
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 14,931
Gujarat Terce Laboratories board meetings
120 filed, newest first. Page 3 of 3.
Jan 2019
Dec 2018
Oct 2018
Aug 2018
10 Aug · Board meeting
May 2018
29 May · Board meeting
Sep 2017
Aug 2017
22 Aug · Board meeting
Jan 2017
Oct 2016
Aug 2016
May 2016
19 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2016, to approve the audited financial results of the Company ....
Mar 2016
21 Mar · Board meeting
Board of Directors, through resolution by circulation passed on March 21, 2016 have taken decision that the Company do file petition ....
Jul 2011
Apr 2011
13 Apr · Board meeting
Board of Directors of the Company at its Meeting held on March 12, 2011, has recommended the members to pass a special resolution ....
Jul 2010
27 Jul · Board meeting
Board of Directors of the Company in the meeting held on June 29, 2010, has decided to create, offer and allot up to 25,00,000 Equity ....
Jun 2010
29 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 29, 2010, has taken following decisions: 1. To issue 32,80,200 ....23 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 22, 2010, inter alia, has taken the following decisions: 1. ....